Rory Kirchner

Harvard University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

23h-index3.0kcitations94works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(26), RNA Research and Splicing(25), Molecular Biology Techniques and Applications(16), RNA and protein synthesis mechanisms(8), Liver Disease Diagnosis and Treatment(6)

Publications94 total

Anti-NMDAR encephalitis across the lifespan: Clinical, electrophysiological, and prognostic insights from a Latin American cohort
Journal of Neuroimmunology·2025
Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells
Nature Communications·2025· 2 citedOpen Access
ML-driven design of 3’ UTRs for mRNA stability
2024· 7 citedOpen Access
Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells
2023· 1 citedOpen Access
Table S1 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Figures S1-S7 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Tables S6-S7 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Table S1 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Data from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Table S11 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Tables S12-S13 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Tables S2_S10_S14 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Tables_S3_S5 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Tables_S3_S5 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Figures S1-S7 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Table S11 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Tables S2_S10_S14 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Supplementary Data from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Tables S12-S13 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
Tables S6-S7 from Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Brad Chapman(9), Oliver Hofmann(9), Lorena Pantano(8), Shannan Ho Sui(7), Yoshihide Hayashizaki(7), Rudolph E. Tanzi(5), Víctor Barrera(5), Michael J. Steinbaugh(4), Kevin Eggan(4), Dmitry Prokopenko(4), Kristina Mullin(4), Judy Lieberman(4), Jennifer Y. Chen(4), Cheng Sun(4), Robert P. Sparks(4), Sean P. Moran(4), David M. Wrobel(4), Shannan J. Ho Sui(4), Julia F. Doerner(4), Jörg F. Rippmann(4)